Fund HoldingsCormorant Asset Management, LP

Total Portfolio Value
$1.34B
Total Bought
$120.34M
Total Sold
$147.61M
Net Transaction
-$27.27M
Filing Period:
Securities
SharesValue ($K)
Q1 2025
Q2 2025
Change
Q1 2025
Q2 2025
Weight (%)
Change
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)8,494,1518,494,1510331,866400,92429.86%+69,057
EYEPOINT PHARMACEUTICALS INC(EYPT)8,325,0008,325,000045,12278,3385.84%+33,217
VERONA PHARMA PLC0350,000+350,000033,1032.47%+33,103
MERUS N V740,0001,120,000+380,00031,14758,9124.39%+27,765
INSMED INC(INSM)525,000540,000+15,00040,05254,3464.05%+14,293
CABALETTA BIO INC05,000,000+5,000,00007,6000.57%+7,600
AARDVARK THERAPEUTICS INC800,189800,18906,00910,8190.81%+4,809
RAPPORT THERAPEUTICS INC(RAPP)2,940,9212,940,921029,49733,4382.49%+3,941
CORBUS PHARMACEUTICALS HLDGS2,375,0002,375,000012,61116,3881.22%+3,776
ABIVAX SA(ABVX)2,130,0002,130,000013,31316,2951.21%+2,982
MBX BIOSCIENCES INC(MBX)700,000700,00005,1667,9870.59%+2,821
PHARVARIS N V
COM
1,466,4601,454,660-11,80023,02325,6021.91%+2,579
GH RESEARCH PLC(GHRS)2,009,4822,009,482022,16524,4961.82%+2,331
VYNE THERAPEUTICS INC01,370,938+1,370,93802,2620.17%+2,262
PRAXIS PRECISION MEDICINES I(PRAX)1,745,0001,625,000-120,00066,08368,3315.09%+2,248
STOKE THERAPEUTICS INC(STOK)254,161254,16101,6902,8850.21%+1,195
METSERA INC400,000400,000010,88811,3800.85%+492
CARGO THERAPEUTICS INC3,381,2773,381,277013,76213,9311.04%+169
BRIDGEBIO PHARMA INC(BBIO)2,000,0001,600,000-400,00069,14069,0885.15%-52
BIOHAVEN LTD(BHVN)10,00010,00002401410.01%-99
KALA BIO INC603,027603,02703,4552,8700.21%-585
KORRO BIO INC380,303465,000+84,6976,6215,8080.43%-813
ENLIVEN THERAPEUTICS INC250,000200,000-50,0004,9204,0120.30%-908
VAXCYTE INC(PCVX)175,000175,00006,6085,6890.42%-919
ARS PHARMACEUTICALS INC1,600,0001,100,000-500,00020,12819,1951.43%-933
BIOAGE LABS INC2,629,5292,140,605-488,9249,8878,8410.66%-1,046
BIOMEA FUSION INC3,570,8723,570,87207,6066,4280.48%-1,178
ENGENE HOLDINGS INC
COM
2,323,5952,323,595010,4108,4580.63%-1,952
HELIX ACQUISITION CORP II2,909,0002,909,000032,87230,8942.30%-1,978
CG ONCOLOGY INC(CGON)775,000625,000-150,00018,98016,2501.21%-2,730
JANUX THERAPEUTICS INC(JANX)(Call)150,0000-150,0004,0500-4,050
PLIANT THERAPEUTICS INC3,000,0000-3,000,0004,0500-4,050
CENTESSA PHARMACEUTICALS PLC2,261,6002,086,600-175,00032,52227,4182.04%-5,104
NEWAMSTERDAM PHARMA COMPANY(Call)
ORDINARY SHARES
250,0000-250,0005,1180-5,117
AVIDITY BIOSCIENCES INC400,000200,000-200,00011,8085,6800.42%-6,128
ALUMIS INC2,147,3962,147,396013,1856,4420.48%-6,743
ARCUTIS BIOTHERAPEUTICS INC(ARQT)1,350,0001,000,000-350,00021,11414,0201.04%-7,094
ONKURE THERAPEUTICS INC1,837,7390-1,837,7397,9020-7,902
RHYTHM PHARMACEUTICALS INC(RYTM)150,0000-150,0007,9460-7,945
TARSUS PHARMACEUTICALS INC(TARS)400,000300,000-100,00020,54812,1530.91%-8,395
CRINETICS PHARMACEUTICALS IN(CRNX)600,000400,000-200,00020,12411,5040.86%-8,620
BRIGHT MINDS BIOSCIENCES INC1,059,3311,059,331038,21027,6592.06%-10,551
ARCELLX INC
COMMON STOCK
1,050,000800,000-250,00068,88052,6803.92%-16,200
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
2,825,0002,175,000-650,00057,82839,3892.93%-18,438
AXSOME THERAPEUTICS INC(AXSM)250,000100,000-150,00029,15810,4390.78%-18,718
JANUX THERAPEUTICS INC(JANX)2,000,0001,500,000-500,00054,00034,6502.58%-19,350
EDGEWISE THERAPEUTICS INC(EWTX)4,101,9924,251,992+150,00090,24455,7444.15%-34,500
Page 1 of 1